U
Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
E
Sell
6/12/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 6/12/2023 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 6/12/2023 due to an increase in the volatility index.
E
Sell
5/25/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 5/25/2023 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 5/25/2023 due to a decline in the volatility index.
E
Sell
5/8/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 5/8/2023 due to an increase in the growth index and volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 5/8/2023 due to an increase in the growth index and volatility index.
E
Sell
4/20/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 4/20/2023 due to a decline in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 4/20/2023 due to a decline in the volatility index and total return index.
E
Sell
3/31/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 3/31/2023 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to E+ from E on 3/31/2023 due to an increase in the volatility index.
E
Sell
3/16/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 3/16/2023 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to E from E+ on 3/16/2023 due to a decline in the volatility index.
E
Sell
3/14/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
D
Sell
3/1/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 3/1/2023 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 3/1/2023 due to a decline in the volatility index.
D
Sell
2/10/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 2/10/2023 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 2/10/2023 due to an increase in the volatility index.
D
Sell
2/9/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E on 2/9/2023 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E from D on 2/8/2023 due to a decline in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was downgraded to E from D on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
1/26/2023Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 1/26/2023 due to an increase in the valuation index and volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 1/26/2023 due to an increase in the valuation index and volatility index.
D
Sell
1/10/2023Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 1/10/2023 due to a decline in the valuation index and volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 1/10/2023 due to a decline in the valuation index and volatility index.
D
Sell
12/19/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index and valuation index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index and valuation index.
D
Sell
12/2/2022Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
D
Sell
11/16/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 11/16/2022 due to an increase in the volatility index and growth index. Operating cash flow increased 26.66% from -$4.57M to -$3.35M, earnings per share increased from -$0.6676 to -$0.5929, and EBIT increased 7.13% from -$5.02M to -$4.66M.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 11/16/2022 due to an increase in the volatility index and growth index. Operating cash flow increased 26.66% from -$4.57M to -$3.35M, earnings per share increased from -$0.6676 to -$0.5929, and EBIT increased 7.13% from -$5.02M to -$4.66M.
D
Sell
11/10/2022Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 11/10/2022 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 11/10/2022 due to a decline in the volatility index.
D
Sell
10/21/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index.
D
Sell
10/6/2022Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 10/6/2022 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 10/6/2022 due to a decline in the volatility index.
D
Sell
9/16/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 9/16/2022 due to an increase in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 9/16/2022 due to an increase in the volatility index and total return index.
D
Sell
8/31/2022Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 8/31/2022 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 8/31/2022 due to a decline in the volatility index.
D
Sell
8/15/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 8/15/2022 due to an increase in the growth index and volatility index. Operating cash flow increased 10.2% from -$5.09M to -$4.57M, total revenue increased 9.38% from $1.64M to $1.8M, and EBIT increased 8.28% from -$5.47M to -$5.02M.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 8/15/2022 due to an increase in the growth index and volatility index. Operating cash flow increased 10.2% from -$5.09M to -$4.57M, total revenue increased 9.38% from $1.64M to $1.8M, and EBIT increased 8.28% from -$5.47M to -$5.02M.
D
Sell
5/5/2022Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 5/5/2022 due to an increase in the growth index and volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 5/5/2022 due to an increase in the growth index and volatility index.
E
Sell
4/20/2022Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 4/20/2022 due to a decline in the growth index, solvency index and total return index. Debt to equity increased from 0.25 to 0.36, the quick ratio declined from 6.02 to 4.35, and operating cash flow declined 21.18% from -$2.66M to -$3.23M.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 4/20/2022 due to a decline in the growth index, solvency index and total return index. Debt to equity increased from 0.25 to 0.36, the quick ratio declined from 6.02 to 4.35, and operating cash flow declined 21.18% from -$2.66M to -$3.23M.
D
Sell
12/16/2021Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 12/16/2021 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.4922 to -$0.6654, the quick ratio declined from 8.83 to 6.02, and debt to equity increased from 0.2 to 0.25.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 12/16/2021 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.4922 to -$0.6654, the quick ratio declined from 8.83 to 6.02, and debt to equity increased from 0.2 to 0.25.
D
Sell
11/9/2021Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from E+ on 11/09/2021.
Viveve Medical, Inc. (VIVE) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D on 11/08/2021.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D on 11/08/2021.
D
Sell
5/7/2021Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 5/7/2021 due to an increase in the total return index and volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 5/7/2021 due to an increase in the total return index and volatility index.
D
Sell
4/22/2021Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 4/22/2021 due to a decline in the volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 4/22/2021 due to a decline in the volatility index.
D
Sell
4/7/2021Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 4/7/2021 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 4/7/2021 due to an increase in the volatility index.
D
Sell
3/22/2021Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 3/22/2021 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.53 to 0.86, the quick ratio declined from 2.95 to 1.73, and EBIT declined 27% from -$3.4M to -$4.32M.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 3/22/2021 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.53 to 0.86, the quick ratio declined from 2.95 to 1.73, and EBIT declined 27% from -$3.4M to -$4.32M.
D
Sell
11/16/2020Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 11/16/2020 due to a noticeable increase in the growth index, total return index and solvency index. Total revenue increased 116.48% from $704 to $1.52M, earnings per share increased from -$0.5735 to -$0.2648, and the quick ratio increased from 2.05 to 2.95.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 11/16/2020 due to a noticeable increase in the growth index, total return index and solvency index. Total revenue increased 116.48% from $704 to $1.52M, earnings per share increased from -$0.5735 to -$0.2648, and the quick ratio increased from 2.05 to 2.95.
D
Sell
5/15/2020Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 5/15/2020 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.26 to 0.35, total revenue declined 10.13% from $1.45M to $1.3M, and operating cash flow declined 6.74% from -$5.37M to -$5.74M.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 5/15/2020 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.26 to 0.35, total revenue declined 10.13% from $1.45M to $1.3M, and operating cash flow declined 6.74% from -$5.37M to -$5.74M.
D
Sell
5/1/2020Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from E+ on 5/1/2020 due to an increase in the growth index, solvency index and total return index.
Viveve Medical, Inc. (VIVE) was upgraded to D from E+ on 5/1/2020 due to an increase in the growth index, solvency index and total return index.
E
Sell
3/30/2020Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/30/2020 due to a decline in the growth index and volatility index. EBIT declined 8.04% from -$6.53M to -$7.05M.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/30/2020 due to a decline in the growth index and volatility index. EBIT declined 8.04% from -$6.53M to -$7.05M.
D
Sell
3/18/2020Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 3/18/2020 due to an increase in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 3/18/2020 due to an increase in the volatility index and total return index.
E
Sell
3/2/2020Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/2/2020 due to a decline in the volatility index and total return index.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/2/2020 due to a decline in the volatility index and total return index.
D
Sell
2/13/2020Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 2/13/2020 due to an increase in the volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 2/13/2020 due to an increase in the volatility index.
E
Sell
11/12/2019Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 11/12/2019 due to a decline in the volatility index, total return index and solvency index. Debt to equity increased from -2.31 to -2.14.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 11/12/2019 due to a decline in the volatility index, total return index and solvency index. Debt to equity increased from -2.31 to -2.14.
D
Sell
5/15/2019Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 5/15/2019 due to an increase in the solvency index, valuation index and growth index. Debt to equity declined from 6.21 to -6.74, earnings per share increased from -$0.3802 to -$0.22, and EBIT increased 34.5% from -$12.27M to -$8.04M.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 5/15/2019 due to an increase in the solvency index, valuation index and growth index. Debt to equity declined from 6.21 to -6.74, earnings per share increased from -$0.3802 to -$0.22, and EBIT increased 34.5% from -$12.27M to -$8.04M.
E
Sell
3/29/2019Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/29/2019 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from -10.89 to 6.21.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 3/29/2019 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from -10.89 to 6.21.
D
Sell
9/5/2018Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 9/5/2018 due to an increase in the total return index and volatility index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 9/5/2018 due to an increase in the total return index and volatility index.
E
Sell
8/14/2018Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 8/14/2018 due to a decline in the solvency index, valuation index and total return index. Debt to equity increased from 1.55 to 3.42, and the quick ratio declined from 5.59 to 3.7.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 8/14/2018 due to a decline in the solvency index, valuation index and total return index. Debt to equity increased from 1.55 to 3.42, and the quick ratio declined from 5.59 to 3.7.
D
Sell
7/5/2018Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 7/5/2018 due to an increase in the valuation index and total return index.
Viveve Medical, Inc. (VIVE) was upgraded to D- from E+ on 7/5/2018 due to an increase in the valuation index and total return index.
E
Sell
6/19/2018Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 6/19/2018 due to a substantial decline in the total return index and volatility index.
Viveve Medical, Inc. (VIVE) was downgraded to E+ from D- on 6/19/2018 due to a substantial decline in the total return index and volatility index.
D
Sell
8/11/2017Downgrade
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 8/11/2017 due to a decline in the efficiency index and solvency index. Debt to equity increased from 0.39 to 1.15, net income declined 55.71% from -$6.7M to -$10.43M, and total capital declined 0.16% from $34.44M to $34.39M.
Viveve Medical, Inc. (VIVE) was downgraded to D- from D on 8/11/2017 due to a decline in the efficiency index and solvency index. Debt to equity increased from 0.39 to 1.15, net income declined 55.71% from -$6.7M to -$10.43M, and total capital declined 0.16% from $34.44M to $34.39M.
D
Sell
5/12/2017Upgraded
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 5/12/2017 due to an increase in the efficiency index, solvency index and total return index. Total capital increased 273.36% from $9.22M to $34.44M, and the quick ratio increased from 1.43 to 4.26.
Viveve Medical, Inc. (VIVE) was upgraded to D from D- on 5/12/2017 due to an increase in the efficiency index, solvency index and total return index. Total capital increased 273.36% from $9.22M to $34.44M, and the quick ratio increased from 1.43 to 4.26.
D
Sell
4/17/2017None
Viveve Medical, Inc. (VIVE) was downgraded to D- from U on 04/17/2017.
Viveve Medical, Inc. (VIVE) was downgraded to D- from U on 04/17/2017.
OTC PK
04/02/2025 3:39PM Eastern
Quotes delayed
